Rosalie Viney
Viney, Rosalie
VIAF ID: 199999733 (Personal)
Permalink: http://viaf.org/viaf/199999733
Preferred Forms
- 100 0 _ ‡a Rosalie Viney
-
- 100 1 _ ‡a Viney, Rosalie
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Are the true impacts of adverse events considered in economic models of antineoplastic drugs? A systematic review. | |
Assessing the value of hospital-in-the-home: lessons from Australia. | |
Breaking up is hard to do: why disinvestment in medical technology is harder than investment. | |
Can administrative data be used to measure chemotherapy side effects? | |
A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE). | |
Comment: out of the mouths of babes. | |
Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises. | |
Consideration Sets and Their Role in Modelling Doctor Recommendations About Contraceptives. | |
Costing Alternative Birth Settings for Women at Low Risk of Complications: A Systematic Review | |
Critical appraisal of health-state utility values used in breast cancer-related cost-utility analyses | |
Decisions about Pap tests: What influences women and providers? | |
Deriving a preference-based utility measure for cancer patients from the European Organisation for the Research and Treatment of Cancer's Quality of Life Questionnaire C30: a confirmatory versus exploratory approach | |
Diagnosis and prognosis of Australia's health information for evidence-based policy. | |
Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review | |
Does mode of administration matter? Comparison of online and face-to-face administration of a time trade-off task. | |
The effect of adverse information and positive promotion on women's preferences for prescribed contraceptive products | |
EFFICIENCY AND EQUITY: A STATED PREFERENCE APPROACH | |
Empirical investigation of experimental design properties of discrete choice experiments in health care | |
Evaluating the Impact of Hospital Based Drug and Alcohol Consultation Liaison Services. | |
Factors that drive the gap in diabetes rates between Aboriginal and non-Aboriginal people in non-remote NSW. | |
From flying doctor to virtual doctor: an economic perspective on Australia's telemedicine experience | |
Funding of drugs: do vaccines warrant a different approach? | |
The hidden costs of drug and alcohol use in hospital emergency departments | |
High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population level | |
How Should DCE with Duration Choice Sets Be Presented for the Valuation of Health States? | |
The impact of childhood language difficulties on healthcare costs from 4 to 13 years: Australian longitudinal study. | |
The Impact of Different DCE-Based Approaches When Anchoring Utility Scores. | |
Improving clinician-carer communication for safer hospital care: a study of the 'TOP 5' strategy in patients with dementia. | |
Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study | |
Individual preferences for diet and exercise programmes: changes over a lifestyle intervention and their link with outcomes. | |
International comparisons in valuing EQ-5D health states: a review and analysis | |
Linking measures of health gain to explicit priority setting by an area health service in Australia. | |
Meeting the information needs of a national drug payer: aspirations of the guidelines from Australia | |
Order of Presentation of Dimensions Does Not Systematically Bias Utility Weights from a Discrete Choice Experiment | |
The PACT study protocol: a time series study investigating the impact, acceptability and cost of an integrated model for psychosocial screening, care and treatment of patients with urological and head and neck cancers | |
Preferences for cancer treatments: an overview of methods and applications in oncology | |
QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30. | |
Quality of Life and Survival in the 2 Years After Surgery for Non–Small-Cell Lung Cancer | |
Randomized Controlled Trial of the Role of Positron Emission Tomography in the Management of Stage I and II Non-Small-Cell Lung Cancer | |
Real-World Evidence: A Comparison of the Australian Herceptin Program and Clinical Trials of Trastuzumab for HER2-Positive Metastatic Breast Cancer. | |
Resource use, costs and quality of end-of-life care: observations in a cohort of elderly Australian cancer decedents | |
Response Patterns in Health State Valuation Using Endogenous Attribute Attendance and Latent Class Analysis. | |
The SF-6Dv2: How Does the New Classification System Impact the Distribution of Responses Compared with the Original SF-6D? | |
A Study Protocol for the Australasian Oncofertility Registry: Monitoring Referral Patterns and the Uptake, Quality, and Complications of Fertility Preservation Strategies in Australia and New Zealand | |
Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer | |
Taking a count: the evaluation of genetic testing | |
Tell me once, tell me soon: parents' preferences for clinical genetics services for congenital heart disease. | |
Time trade-off derived EQ-5D weights for Australia. | |
To HITH or not to HITH: making a decision about establishing hospital in the home | |
The use of QALY weights for QALY calculations: a review of industry submissions requesting listing on the Australian Pharmaceutical Benefits Scheme 2002-4. | |
Using programme budgeting and marginal analysis to assist population based strategic planning for coronary heart disease | |
Using repeated choice experiments to evaluate the impact of policy changes on cervical screening | |
Using stated preference discrete choice modelling to evaluate the introduction of varicella vaccination | |
Value for money in drug treatment: economic evaluation of prison methadone | |
Valuing Meta-Health Effects for Use in Economic Evaluations to Inform Reimbursement Decisions: A Review of the Evidence | |
Valuing SF-6D Health States Using a Discrete Choice Experiment. | |
What's good and bad about contraceptive products?: a best-worst attribute experiment comparing the values of women consumers and GPs. | |
Whither private health insurance? | |
Who's Getting Caught? An Analysis of the Australian Medicare Safety Net | |
Why worry about awareness in choice problems? Econometric analysis of screening for cervical cancer |